ARK Investment Management’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVGN
SM
EVC
VIA
ARK Investment Management's EVGN Position: Q1 2022 in Review
ARK Investment Management sold out of Evogene (EVGN) in Q1 2022, closing a stake of 361,184 shares — an estimated $6.02M sold.
ARK Investment Management first reported a position in EVGN in Q4 2016 and held it in 21 quarters. The position peaked at $24.2M in Q1 2021. 38 funds tracked by Wall St. Rank hold EVGN as of Q1 2022.
- ARK Investment Management reported no remaining Evogene position as of Q1 2022 after selling out during the quarter.
- ARK Investment Management sold 361,184 Evogene shares in Q1 2022, an estimated $6.02M.
- ARK Investment Management first reported a position in Evogene in Q4 2016 and held it in 21 quarters.
- ARK Investment Management's Evogene position peaked at $24.2M in Q1 2021.
- 38 funds tracked by Wall St. Rank held Evogene as of Q1 2022.
Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.